BioAscent will be attending the BMCS 2nd Conformational Design in Drug Discovery symposium on 3 March 2025 at AstraZeneca, Cambridge.

Conformational Design plays a key role in the medicinal chemistry of small molecule drug candidates and the symposium will be an excellent opportunity for colleagues within medicinal and computational chemistry to discuss strategies, technologies and case studies.

If you would like to arrange a meeting, please get in touch by emailing info@bioascent.com.

To find out more about the symposium, click here.